Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
Is the 82-Fold ROI of AI in Clinical Trials a Site Burden?
Research & Development Is the 82-Fold ROI of AI in Clinical Trials a Site Burden?

The clinical research industry is currently weathering a transformative storm where the sheer velocity of data collection frequently outpaces the logistical capacity of the human teams working on the front lines of patient care. While high-level financial metrics suggest an unprecedented era of

Are Foundation Models Ready for Real-World Medical Imaging?
Tech & Innovation Are Foundation Models Ready for Real-World Medical Imaging?

The rapid proliferation of foundation models has fundamentally altered the trajectory of medical diagnostics, promising a shift from specialized algorithms to versatile, general-purpose systems. While early diagnostic software focused exclusively on isolated tasks like detecting lung nodules or

Trinity Health Hospitals Lead CT in Serious Safety Citations
Management & Regulatory Trinity Health Hospitals Lead CT in Serious Safety Citations

When families entrust their loved ones to the care of major medical institutions, they operate under the assumption that rigorous safety protocols and expert oversight are the baseline of every interaction. However, recent data concerning Connecticut’s healthcare landscape has shattered this sense

Can Daraxonrasib Lead a New Era of Adaptive Oncology Trials?
Research & Development Can Daraxonrasib Lead a New Era of Adaptive Oncology Trials?

The treatment landscape for pancreatic ductal adenocarcinoma has long been characterized by a disheartening series of clinical failures and marginal survival improvements that left patients with few viable options. However, the emergence of daraxonrasib, a specialized oral RAS(ON) multi-selective

AI Foundation Model Enhances Abdominal Emergency Triage
Tech & Innovation AI Foundation Model Enhances Abdominal Emergency Triage

The diagnostic process for sudden abdominal pain remains one of the most high-stakes challenges within modern emergency departments because symptoms often manifest identically across both trivial and fatal conditions. Medical professionals frequently find themselves in a race against the clock,

How Safe Is the WiSE Wireless Cardiac Pacing System?
Tech & Innovation How Safe Is the WiSE Wireless Cardiac Pacing System?

The rapid integration of wireless technologies into the human cardiovascular system has introduced a set of unprecedented clinical challenges that force medical professionals to reconsider the traditional boundaries of patient safety and device efficacy. EBR Systems, a prominent medical technology

Can AI-Augmented Care End the Retinal Diagnostic Odyssey?
Tech & Innovation Can AI-Augmented Care End the Retinal Diagnostic Odyssey?

A patient suffering from an undiagnosed visual impairment often spends more than half a decade circulating through various clinical settings before finally receiving a definitive genetic answer for their condition. This prolonged period of uncertainty, frequently referred to as a diagnostic

Why Must Preventive Care Redefine Modern Medicine?
Tech & Innovation Why Must Preventive Care Redefine Modern Medicine?

The traditional healthcare paradigm, long centered on the reactive treatment of acute symptoms and advanced disease states, is facing an unsustainable trajectory as chronic conditions continue to drain global resources. This systemic shift toward prevention is not merely a philosophical preference

Can Off-the-Shelf Cell Therapy Transform Cancer Care?
Research & Development Can Off-the-Shelf Cell Therapy Transform Cancer Care?

The medical landscape underwent a seismic shift recently when the Christie NHS Foundation Trust and the Royal Marsden launched the ZI-MA4-1 clinical trial, marking a pivotal moment for patients diagnosed with advanced solid tumors that have resisted standard treatments. For individuals like Tracy

How Can Pharma Achieve Sustainable Oral Drug Delivery?
Management & Regulatory How Can Pharma Achieve Sustainable Oral Drug Delivery?

Global healthcare systems currently grapple with a paradoxical challenge where the very treatments designed to save lives simultaneously degrade the environment through intensive carbon emissions. While medical breakthroughs continue to extend human longevity, the manufacturing processes supporting

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later